The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Urine in Vitro Diagnostics Market Research Report 2025
Synopsis
Urine in vitro diagnostics (IVD) involve the analysis of urine samples to obtain information about various aspects of an individual's health. Urine is a valuable biological fluid that can provide insights into kidney function, metabolic processes, and the presence of certain substances or markers.
The global Urine in Vitro Diagnostics market was valued at US$ 22540 million in 2023 and is anticipated to reach US$ 33510 million by 2030, witnessing a CAGR of 6.0% during the forecast period 2024-2030.
The Urine In Vitro Diagnostics market is driven by the essential role urine analysis plays in assessing various health conditions. In vitro diagnostic devices dedicated to urine testing, such as urinalysis strips, urine chemistry analyzers, and automated urine sediment analyzers, are instrumental in detecting disorders related to the urinary system, diabetes, kidney diseases, and metabolic conditions. The market benefits from the increasing prevalence of such health issues and the need for efficient and cost-effective diagnostic solutions. The simplicity and non-invasiveness of urine sample collection contribute to the widespread adoption of urine in vitro diagnostics, making it a fundamental component of routine medical examinations and disease management.
This report aims to provide a comprehensive presentation of the global market for Urine in Vitro Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Urine in Vitro Diagnostics.
Report Scope
The Urine in Vitro Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Urine in Vitro Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Urine in Vitro Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Siemens
Abbott
Danaher
Thermo Fisher
BioMerieux
Bio-Rad
BD
KHB
Daan Gene
Leadman
Zhongsheng
Bsbe
Maccura
Hitachi
Canon
Sysmex
Auto Bio
Mindray
Bgi
Wondfo
Segment by Type
Consumables
Equipment
Segment by Application
Drug Testing
Infectious Disease Testing
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Urine in Vitro Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Urine in vitro diagnostics (IVD) involve the analysis of urine samples to obtain information about various aspects of an individual's health. Urine is a valuable biological fluid that can provide insights into kidney function, metabolic processes, and the presence of certain substances or markers.
The global Urine in Vitro Diagnostics market was valued at US$ 22540 million in 2023 and is anticipated to reach US$ 33510 million by 2030, witnessing a CAGR of 6.0% during the forecast period 2024-2030.
The Urine In Vitro Diagnostics market is driven by the essential role urine analysis plays in assessing various health conditions. In vitro diagnostic devices dedicated to urine testing, such as urinalysis strips, urine chemistry analyzers, and automated urine sediment analyzers, are instrumental in detecting disorders related to the urinary system, diabetes, kidney diseases, and metabolic conditions. The market benefits from the increasing prevalence of such health issues and the need for efficient and cost-effective diagnostic solutions. The simplicity and non-invasiveness of urine sample collection contribute to the widespread adoption of urine in vitro diagnostics, making it a fundamental component of routine medical examinations and disease management.
This report aims to provide a comprehensive presentation of the global market for Urine in Vitro Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Urine in Vitro Diagnostics.
Report Scope
The Urine in Vitro Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Urine in Vitro Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Urine in Vitro Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Siemens
Abbott
Danaher
Thermo Fisher
BioMerieux
Bio-Rad
BD
KHB
Daan Gene
Leadman
Zhongsheng
Bsbe
Maccura
Hitachi
Canon
Sysmex
Auto Bio
Mindray
Bgi
Wondfo
Segment by Type
Consumables
Equipment
Segment by Application
Drug Testing
Infectious Disease Testing
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Urine in Vitro Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Urine in Vitro Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Consumables
1.2.3 Equipment
1.3 Market by Application
1.3.1 Global Urine in Vitro Diagnostics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Drug Testing
1.3.3 Infectious Disease Testing
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Urine in Vitro Diagnostics Market Perspective (2019-2030)
2.2 Urine in Vitro Diagnostics Growth Trends by Region
2.2.1 Global Urine in Vitro Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Urine in Vitro Diagnostics Historic Market Size by Region (2019-2024)
2.2.3 Urine in Vitro Diagnostics Forecasted Market Size by Region (2025-2030)
2.3 Urine in Vitro Diagnostics Market Dynamics
2.3.1 Urine in Vitro Diagnostics Industry Trends
2.3.2 Urine in Vitro Diagnostics Market Drivers
2.3.3 Urine in Vitro Diagnostics Market Challenges
2.3.4 Urine in Vitro Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Urine in Vitro Diagnostics Players by Revenue
3.1.1 Global Top Urine in Vitro Diagnostics Players by Revenue (2019-2024)
3.1.2 Global Urine in Vitro Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global Urine in Vitro Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Urine in Vitro Diagnostics Revenue
3.4 Global Urine in Vitro Diagnostics Market Concentration Ratio
3.4.1 Global Urine in Vitro Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Urine in Vitro Diagnostics Revenue in 2023
3.5 Urine in Vitro Diagnostics Key Players Head office and Area Served
3.6 Key Players Urine in Vitro Diagnostics Product Solution and Service
3.7 Date of Enter into Urine in Vitro Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Urine in Vitro Diagnostics Breakdown Data by Type
4.1 Global Urine in Vitro Diagnostics Historic Market Size by Type (2019-2024)
4.2 Global Urine in Vitro Diagnostics Forecasted Market Size by Type (2025-2030)
5 Urine in Vitro Diagnostics Breakdown Data by Application
5.1 Global Urine in Vitro Diagnostics Historic Market Size by Application (2019-2024)
5.2 Global Urine in Vitro Diagnostics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Urine in Vitro Diagnostics Market Size (2019-2030)
6.2 North America Urine in Vitro Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Urine in Vitro Diagnostics Market Size by Country (2019-2024)
6.4 North America Urine in Vitro Diagnostics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Urine in Vitro Diagnostics Market Size (2019-2030)
7.2 Europe Urine in Vitro Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Urine in Vitro Diagnostics Market Size by Country (2019-2024)
7.4 Europe Urine in Vitro Diagnostics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Urine in Vitro Diagnostics Market Size (2019-2030)
8.2 Asia-Pacific Urine in Vitro Diagnostics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Urine in Vitro Diagnostics Market Size by Region (2019-2024)
8.4 Asia-Pacific Urine in Vitro Diagnostics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Urine in Vitro Diagnostics Market Size (2019-2030)
9.2 Latin America Urine in Vitro Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Urine in Vitro Diagnostics Market Size by Country (2019-2024)
9.4 Latin America Urine in Vitro Diagnostics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Urine in Vitro Diagnostics Market Size (2019-2030)
10.2 Middle East & Africa Urine in Vitro Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Urine in Vitro Diagnostics Market Size by Country (2019-2024)
10.4 Middle East & Africa Urine in Vitro Diagnostics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Detail
11.1.2 Roche Business Overview
11.1.3 Roche Urine in Vitro Diagnostics Introduction
11.1.4 Roche Revenue in Urine in Vitro Diagnostics Business (2019-2024)
11.1.5 Roche Recent Development
11.2 Siemens
11.2.1 Siemens Company Detail
11.2.2 Siemens Business Overview
11.2.3 Siemens Urine in Vitro Diagnostics Introduction
11.2.4 Siemens Revenue in Urine in Vitro Diagnostics Business (2019-2024)
11.2.5 Siemens Recent Development
11.3 Abbott
11.3.1 Abbott Company Detail
11.3.2 Abbott Business Overview
11.3.3 Abbott Urine in Vitro Diagnostics Introduction
11.3.4 Abbott Revenue in Urine in Vitro Diagnostics Business (2019-2024)
11.3.5 Abbott Recent Development
11.4 Danaher
11.4.1 Danaher Company Detail
11.4.2 Danaher Business Overview
11.4.3 Danaher Urine in Vitro Diagnostics Introduction
11.4.4 Danaher Revenue in Urine in Vitro Diagnostics Business (2019-2024)
11.4.5 Danaher Recent Development
11.5 Thermo Fisher
11.5.1 Thermo Fisher Company Detail
11.5.2 Thermo Fisher Business Overview
11.5.3 Thermo Fisher Urine in Vitro Diagnostics Introduction
11.5.4 Thermo Fisher Revenue in Urine in Vitro Diagnostics Business (2019-2024)
11.5.5 Thermo Fisher Recent Development
11.6 BioMerieux
11.6.1 BioMerieux Company Detail
11.6.2 BioMerieux Business Overview
11.6.3 BioMerieux Urine in Vitro Diagnostics Introduction
11.6.4 BioMerieux Revenue in Urine in Vitro Diagnostics Business (2019-2024)
11.6.5 BioMerieux Recent Development
11.7 Bio-Rad
11.7.1 Bio-Rad Company Detail
11.7.2 Bio-Rad Business Overview
11.7.3 Bio-Rad Urine in Vitro Diagnostics Introduction
11.7.4 Bio-Rad Revenue in Urine in Vitro Diagnostics Business (2019-2024)
11.7.5 Bio-Rad Recent Development
11.8 BD
11.8.1 BD Company Detail
11.8.2 BD Business Overview
11.8.3 BD Urine in Vitro Diagnostics Introduction
11.8.4 BD Revenue in Urine in Vitro Diagnostics Business (2019-2024)
11.8.5 BD Recent Development
11.9 KHB
11.9.1 KHB Company Detail
11.9.2 KHB Business Overview
11.9.3 KHB Urine in Vitro Diagnostics Introduction
11.9.4 KHB Revenue in Urine in Vitro Diagnostics Business (2019-2024)
11.9.5 KHB Recent Development
11.10 Daan Gene
11.10.1 Daan Gene Company Detail
11.10.2 Daan Gene Business Overview
11.10.3 Daan Gene Urine in Vitro Diagnostics Introduction
11.10.4 Daan Gene Revenue in Urine in Vitro Diagnostics Business (2019-2024)
11.10.5 Daan Gene Recent Development
11.11 Leadman
11.11.1 Leadman Company Detail
11.11.2 Leadman Business Overview
11.11.3 Leadman Urine in Vitro Diagnostics Introduction
11.11.4 Leadman Revenue in Urine in Vitro Diagnostics Business (2019-2024)
11.11.5 Leadman Recent Development
11.12 Zhongsheng
11.12.1 Zhongsheng Company Detail
11.12.2 Zhongsheng Business Overview
11.12.3 Zhongsheng Urine in Vitro Diagnostics Introduction
11.12.4 Zhongsheng Revenue in Urine in Vitro Diagnostics Business (2019-2024)
11.12.5 Zhongsheng Recent Development
11.13 Bsbe
11.13.1 Bsbe Company Detail
11.13.2 Bsbe Business Overview
11.13.3 Bsbe Urine in Vitro Diagnostics Introduction
11.13.4 Bsbe Revenue in Urine in Vitro Diagnostics Business (2019-2024)
11.13.5 Bsbe Recent Development
11.14 Maccura
11.14.1 Maccura Company Detail
11.14.2 Maccura Business Overview
11.14.3 Maccura Urine in Vitro Diagnostics Introduction
11.14.4 Maccura Revenue in Urine in Vitro Diagnostics Business (2019-2024)
11.14.5 Maccura Recent Development
11.15 Hitachi
11.15.1 Hitachi Company Detail
11.15.2 Hitachi Business Overview
11.15.3 Hitachi Urine in Vitro Diagnostics Introduction
11.15.4 Hitachi Revenue in Urine in Vitro Diagnostics Business (2019-2024)
11.15.5 Hitachi Recent Development
11.16 Canon
11.16.1 Canon Company Detail
11.16.2 Canon Business Overview
11.16.3 Canon Urine in Vitro Diagnostics Introduction
11.16.4 Canon Revenue in Urine in Vitro Diagnostics Business (2019-2024)
11.16.5 Canon Recent Development
11.17 Sysmex
11.17.1 Sysmex Company Detail
11.17.2 Sysmex Business Overview
11.17.3 Sysmex Urine in Vitro Diagnostics Introduction
11.17.4 Sysmex Revenue in Urine in Vitro Diagnostics Business (2019-2024)
11.17.5 Sysmex Recent Development
11.18 Auto Bio
11.18.1 Auto Bio Company Detail
11.18.2 Auto Bio Business Overview
11.18.3 Auto Bio Urine in Vitro Diagnostics Introduction
11.18.4 Auto Bio Revenue in Urine in Vitro Diagnostics Business (2019-2024)
11.18.5 Auto Bio Recent Development
11.19 Mindray
11.19.1 Mindray Company Detail
11.19.2 Mindray Business Overview
11.19.3 Mindray Urine in Vitro Diagnostics Introduction
11.19.4 Mindray Revenue in Urine in Vitro Diagnostics Business (2019-2024)
11.19.5 Mindray Recent Development
11.20 Bgi
11.20.1 Bgi Company Detail
11.20.2 Bgi Business Overview
11.20.3 Bgi Urine in Vitro Diagnostics Introduction
11.20.4 Bgi Revenue in Urine in Vitro Diagnostics Business (2019-2024)
11.20.5 Bgi Recent Development
11.21 Wondfo
11.21.1 Wondfo Company Detail
11.21.2 Wondfo Business Overview
11.21.3 Wondfo Urine in Vitro Diagnostics Introduction
11.21.4 Wondfo Revenue in Urine in Vitro Diagnostics Business (2019-2024)
11.21.5 Wondfo Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Urine in Vitro Diagnostics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Consumables
Table 3. Key Players of Equipment
Table 4. Global Urine in Vitro Diagnostics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Urine in Vitro Diagnostics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Urine in Vitro Diagnostics Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Urine in Vitro Diagnostics Market Share by Region (2019-2024)
Table 8. Global Urine in Vitro Diagnostics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Urine in Vitro Diagnostics Market Share by Region (2025-2030)
Table 10. Urine in Vitro Diagnostics Market Trends
Table 11. Urine in Vitro Diagnostics Market Drivers
Table 12. Urine in Vitro Diagnostics Market Challenges
Table 13. Urine in Vitro Diagnostics Market Restraints
Table 14. Global Urine in Vitro Diagnostics Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Urine in Vitro Diagnostics Market Share by Players (2019-2024)
Table 16. Global Top Urine in Vitro Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Urine in Vitro Diagnostics as of 2023)
Table 17. Ranking of Global Top Urine in Vitro Diagnostics Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Urine in Vitro Diagnostics Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Urine in Vitro Diagnostics Product Solution and Service
Table 21. Date of Enter into Urine in Vitro Diagnostics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Urine in Vitro Diagnostics Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Urine in Vitro Diagnostics Revenue Market Share by Type (2019-2024)
Table 25. Global Urine in Vitro Diagnostics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Urine in Vitro Diagnostics Revenue Market Share by Type (2025-2030)
Table 27. Global Urine in Vitro Diagnostics Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Urine in Vitro Diagnostics Revenue Market Share by Application (2019-2024)
Table 29. Global Urine in Vitro Diagnostics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Urine in Vitro Diagnostics Revenue Market Share by Application (2025-2030)
Table 31. North America Urine in Vitro Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Urine in Vitro Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Urine in Vitro Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Urine in Vitro Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Urine in Vitro Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Urine in Vitro Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Urine in Vitro Diagnostics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Urine in Vitro Diagnostics Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Urine in Vitro Diagnostics Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Urine in Vitro Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Urine in Vitro Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Urine in Vitro Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Urine in Vitro Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Urine in Vitro Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Urine in Vitro Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 46. Roche Company Detail
Table 47. Roche Business Overview
Table 48. Roche Urine in Vitro Diagnostics Product
Table 49. Roche Revenue in Urine in Vitro Diagnostics Business (2019-2024) & (US$ Million)
Table 50. Roche Recent Development
Table 51. Siemens Company Detail
Table 52. Siemens Business Overview
Table 53. Siemens Urine in Vitro Diagnostics Product
Table 54. Siemens Revenue in Urine in Vitro Diagnostics Business (2019-2024) & (US$ Million)
Table 55. Siemens Recent Development
Table 56. Abbott Company Detail
Table 57. Abbott Business Overview
Table 58. Abbott Urine in Vitro Diagnostics Product
Table 59. Abbott Revenue in Urine in Vitro Diagnostics Business (2019-2024) & (US$ Million)
Table 60. Abbott Recent Development
Table 61. Danaher Company Detail
Table 62. Danaher Business Overview
Table 63. Danaher Urine in Vitro Diagnostics Product
Table 64. Danaher Revenue in Urine in Vitro Diagnostics Business (2019-2024) & (US$ Million)
Table 65. Danaher Recent Development
Table 66. Thermo Fisher Company Detail
Table 67. Thermo Fisher Business Overview
Table 68. Thermo Fisher Urine in Vitro Diagnostics Product
Table 69. Thermo Fisher Revenue in Urine in Vitro Diagnostics Business (2019-2024) & (US$ Million)
Table 70. Thermo Fisher Recent Development
Table 71. BioMerieux Company Detail
Table 72. BioMerieux Business Overview
Table 73. BioMerieux Urine in Vitro Diagnostics Product
Table 74. BioMerieux Revenue in Urine in Vitro Diagnostics Business (2019-2024) & (US$ Million)
Table 75. BioMerieux Recent Development
Table 76. Bio-Rad Company Detail
Table 77. Bio-Rad Business Overview
Table 78. Bio-Rad Urine in Vitro Diagnostics Product
Table 79. Bio-Rad Revenue in Urine in Vitro Diagnostics Business (2019-2024) & (US$ Million)
Table 80. Bio-Rad Recent Development
Table 81. BD Company Detail
Table 82. BD Business Overview
Table 83. BD Urine in Vitro Diagnostics Product
Table 84. BD Revenue in Urine in Vitro Diagnostics Business (2019-2024) & (US$ Million)
Table 85. BD Recent Development
Table 86. KHB Company Detail
Table 87. KHB Business Overview
Table 88. KHB Urine in Vitro Diagnostics Product
Table 89. KHB Revenue in Urine in Vitro Diagnostics Business (2019-2024) & (US$ Million)
Table 90. KHB Recent Development
Table 91. Daan Gene Company Detail
Table 92. Daan Gene Business Overview
Table 93. Daan Gene Urine in Vitro Diagnostics Product
Table 94. Daan Gene Revenue in Urine in Vitro Diagnostics Business (2019-2024) & (US$ Million)
Table 95. Daan Gene Recent Development
Table 96. Leadman Company Detail
Table 97. Leadman Business Overview
Table 98. Leadman Urine in Vitro Diagnostics Product
Table 99. Leadman Revenue in Urine in Vitro Diagnostics Business (2019-2024) & (US$ Million)
Table 100. Leadman Recent Development
Table 101. Zhongsheng Company Detail
Table 102. Zhongsheng Business Overview
Table 103. Zhongsheng Urine in Vitro Diagnostics Product
Table 104. Zhongsheng Revenue in Urine in Vitro Diagnostics Business (2019-2024) & (US$ Million)
Table 105. Zhongsheng Recent Development
Table 106. Bsbe Company Detail
Table 107. Bsbe Business Overview
Table 108. Bsbe Urine in Vitro Diagnostics Product
Table 109. Bsbe Revenue in Urine in Vitro Diagnostics Business (2019-2024) & (US$ Million)
Table 110. Bsbe Recent Development
Table 111. Maccura Company Detail
Table 112. Maccura Business Overview
Table 113. Maccura Urine in Vitro Diagnostics Product
Table 114. Maccura Revenue in Urine in Vitro Diagnostics Business (2019-2024) & (US$ Million)
Table 115. Maccura Recent Development
Table 116. Hitachi Company Detail
Table 117. Hitachi Business Overview
Table 118. Hitachi Urine in Vitro Diagnostics Product
Table 119. Hitachi Revenue in Urine in Vitro Diagnostics Business (2019-2024) & (US$ Million)
Table 120. Hitachi Recent Development
Table 121. Canon Company Detail
Table 122. Canon Business Overview
Table 123. Canon Urine in Vitro Diagnostics Product
Table 124. Canon Revenue in Urine in Vitro Diagnostics Business (2019-2024) & (US$ Million)
Table 125. Canon Recent Development
Table 126. Sysmex Company Detail
Table 127. Sysmex Business Overview
Table 128. Sysmex Urine in Vitro Diagnostics Product
Table 129. Sysmex Revenue in Urine in Vitro Diagnostics Business (2019-2024) & (US$ Million)
Table 130. Sysmex Recent Development
Table 131. Auto Bio Company Detail
Table 132. Auto Bio Business Overview
Table 133. Auto Bio Urine in Vitro Diagnostics Product
Table 134. Auto Bio Revenue in Urine in Vitro Diagnostics Business (2019-2024) & (US$ Million)
Table 135. Auto Bio Recent Development
Table 136. Mindray Company Detail
Table 137. Mindray Business Overview
Table 138. Mindray Urine in Vitro Diagnostics Product
Table 139. Mindray Revenue in Urine in Vitro Diagnostics Business (2019-2024) & (US$ Million)
Table 140. Mindray Recent Development
Table 141. Bgi Company Detail
Table 142. Bgi Business Overview
Table 143. Bgi Urine in Vitro Diagnostics Product
Table 144. Bgi Revenue in Urine in Vitro Diagnostics Business (2019-2024) & (US$ Million)
Table 145. Bgi Recent Development
Table 146. Wondfo Company Detail
Table 147. Wondfo Business Overview
Table 148. Wondfo Urine in Vitro Diagnostics Product
Table 149. Wondfo Revenue in Urine in Vitro Diagnostics Business (2019-2024) & (US$ Million)
Table 150. Wondfo Recent Development
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Urine in Vitro Diagnostics Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Urine in Vitro Diagnostics Market Share by Type: 2023 VS 2030
Figure 3. Consumables Features
Figure 4. Equipment Features
Figure 5. Global Urine in Vitro Diagnostics Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Urine in Vitro Diagnostics Market Share by Application: 2023 VS 2030
Figure 7. Drug Testing Case Studies
Figure 8. Infectious Disease Testing Case Studies
Figure 9. Other Case Studies
Figure 10. Urine in Vitro Diagnostics Report Years Considered
Figure 11. Global Urine in Vitro Diagnostics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Urine in Vitro Diagnostics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Urine in Vitro Diagnostics Market Share by Region: 2023 VS 2030
Figure 14. Global Urine in Vitro Diagnostics Market Share by Players in 2023
Figure 15. Global Top Urine in Vitro Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Urine in Vitro Diagnostics as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Urine in Vitro Diagnostics Revenue in 2023
Figure 17. North America Urine in Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Urine in Vitro Diagnostics Market Share by Country (2019-2030)
Figure 19. United States Urine in Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Urine in Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Urine in Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Urine in Vitro Diagnostics Market Share by Country (2019-2030)
Figure 23. Germany Urine in Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Urine in Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Urine in Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Urine in Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Urine in Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Urine in Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Urine in Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Urine in Vitro Diagnostics Market Share by Region (2019-2030)
Figure 31. China Urine in Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Urine in Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Urine in Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Urine in Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Urine in Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Urine in Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Urine in Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Urine in Vitro Diagnostics Market Share by Country (2019-2030)
Figure 39. Mexico Urine in Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Urine in Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Urine in Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Urine in Vitro Diagnostics Market Share by Country (2019-2030)
Figure 43. Turkey Urine in Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Urine in Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Roche Revenue Growth Rate in Urine in Vitro Diagnostics Business (2019-2024)
Figure 46. Siemens Revenue Growth Rate in Urine in Vitro Diagnostics Business (2019-2024)
Figure 47. Abbott Revenue Growth Rate in Urine in Vitro Diagnostics Business (2019-2024)
Figure 48. Danaher Revenue Growth Rate in Urine in Vitro Diagnostics Business (2019-2024)
Figure 49. Thermo Fisher Revenue Growth Rate in Urine in Vitro Diagnostics Business (2019-2024)
Figure 50. BioMerieux Revenue Growth Rate in Urine in Vitro Diagnostics Business (2019-2024)
Figure 51. Bio-Rad Revenue Growth Rate in Urine in Vitro Diagnostics Business (2019-2024)
Figure 52. BD Revenue Growth Rate in Urine in Vitro Diagnostics Business (2019-2024)
Figure 53. KHB Revenue Growth Rate in Urine in Vitro Diagnostics Business (2019-2024)
Figure 54. Daan Gene Revenue Growth Rate in Urine in Vitro Diagnostics Business (2019-2024)
Figure 55. Leadman Revenue Growth Rate in Urine in Vitro Diagnostics Business (2019-2024)
Figure 56. Zhongsheng Revenue Growth Rate in Urine in Vitro Diagnostics Business (2019-2024)
Figure 57. Bsbe Revenue Growth Rate in Urine in Vitro Diagnostics Business (2019-2024)
Figure 58. Maccura Revenue Growth Rate in Urine in Vitro Diagnostics Business (2019-2024)
Figure 59. Hitachi Revenue Growth Rate in Urine in Vitro Diagnostics Business (2019-2024)
Figure 60. Canon Revenue Growth Rate in Urine in Vitro Diagnostics Business (2019-2024)
Figure 61. Sysmex Revenue Growth Rate in Urine in Vitro Diagnostics Business (2019-2024)
Figure 62. Auto Bio Revenue Growth Rate in Urine in Vitro Diagnostics Business (2019-2024)
Figure 63. Mindray Revenue Growth Rate in Urine in Vitro Diagnostics Business (2019-2024)
Figure 64. Bgi Revenue Growth Rate in Urine in Vitro Diagnostics Business (2019-2024)
Figure 65. Wondfo Revenue Growth Rate in Urine in Vitro Diagnostics Business (2019-2024)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
